TOPAbout TaihoFinancial Highlights

Financial Highlights

Taiho Pharmaceutical Co., Ltd. Each Fiscal Year Ending March 31

Millions of yenThousands of
U.S. dollars

(Note)

Millions of yen 2013
3/14
2012
3/13
2011
3/12
2010
3/11
2009
3/10
2013
3/14
For the Year:
Net sales ¥125,823 ¥125,002 ¥124,312 ¥123,581 ¥120,716 $1,221,588
Operating income 9,842 15,209 16,328 15,778 14,564 95,556
Net income 7,235 11,164 10,209 12,127 10,464 70,244
Research and development expenses 35,273 30,428 28,094 30,262 29,735 342,465
R&D ratio to net sales (%) 28.0% 24.3% 22.6% 24.5% 24.6% 28.0%
Total assets ¥360,756 ¥363,641 ¥359,792 ¥354,882 ¥346,619 $3,502,491
Net assets 332,766 330,764 324,005 319,333 313,019 3,230,744
Employees 2,527 2,521 2,557 2,622 2,643 2,527

Note. U.S. dollar amounts are translated from yen, for convenience only, at the rate of ¥103=US$1, the approximate exchange rate at March 31, 2014


Top of Page